Inquirer on MSN2h
US approves first-ever obstructive sleep apnea drug
On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
Sleep apnea? Neuro implants promise good night’s rest
WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Community Impact Newspaper10h
Understanding Sleep Disorders with Dr. Aaron Kirkpatrick
According to the Centers for Disease Control and Prevention, roughly one in three adults in the U.S. don’t get enough rest or ...
Bradford Era1d
BRMC’s Sleep Disorders Center achieves milestone in patient care
The sleep disorders center at Bradford Regional Medical Center (BRMC), a Kaleida Health facility, achieved a milestone in ...
Pharmaceutical Technology1d
Dronabinol + palmidrol by Evero Health for Tourette Syndrome: Likelihood of Approval
Dronabinol + palmidrol is under clinical development by Evero Health and currently in Phase II for Tourette Syndrome.
FDA approves Zepbound for sleep apnea in obese adults
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Pharmaceutical Technology1d
Pitolisant hydrochloride by Bioprojet SCR for Autism Spectrum Disorder (ASD): Likelihood of Approval
Pitolisant hydrochloride is under clinical development by Bioprojet SCR and currently in Phase II for Autism Spectrum Disorder (ASD).
Renal & Urology News1d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
psychiatryadvisor.com1d
Pregnancy-Onset OSA Increases Nocturnal and Daytime Blood Pressure
Women with pregnancy-onset OSA had significantly higher nocturnal systolic BP and daytime diastolic BP, relative to those ...
Taiwan News1d
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Inspire is scheduled to present at 11:15 a.m. Eastern Time. The presentation will be accessible via a live webcast here. Webcast replays of the presentations will be available for two weeks following ...